Sonar Delivers Clean Code Solution SonarQube Through Google Cloud Marketplace
Sonar, the leader in Clean Code solutions, today announced that SonarQube is now available on Google Cloud Marketplace, enabling organizations to accelerate DevOps transformations in the cloud, modernize software development workflows, and deliver higher-quality, secure applications. As companies adopt AI code generation tools, SonarQube ensures that no matter where or how code is developed, it leads to secure, reliable, and maintainable software.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240529150627/en/
SonarQube is now available on Google Cloud Marketplace. (Photo: Business Wire)
SonarQube’s availability on Google Cloud Marketplace streamlines the process for developers to identify and address potential issues in code early on in the software development lifecycle (SDLC), whether code is human-developed or AI-generated. Developers can now quickly set up SonarQube in their Google Cloud environment to analyze their code quality with simplified billing and scalability that fit their specific needs and budget. Organizations are empowered to accelerate their DevOps transformation initiatives while minimizing risks and ensuring long-term success.
“Bringing SonarQube to Google Cloud Marketplace will help customers quickly deploy, manage, and grow the solution on Google Cloud's trusted, global infrastructure," said Dai Vu, Managing Director, Marketplace & ISV GTM Programs at Google Cloud. “Sonar can now securely scale and support customers on their digital transformation journeys.”
Google Cloud Marketplace lets users quickly deploy functional software packages that run on Google Cloud's infrastructure. Google Cloud Marketplace allows customers to easily start up a familiar software package with services like Compute Engine or Cloud Storage, with no manual configuration required.
Over the last 15 years, Sonar has analyzed more than half a trillion lines of code across all industries and company sizes, resulting in a deep understanding of how code is written and managed. Sonar evaluates code for quality and security issues at two points - in the IDE with SonarLint, and in the Continuous Integration (CI) pipeline, with SonarQube. Sonar’s offering is built on the principles of Clean Code, which is the belief that when code is consistent, intentional, adaptable, and responsible – meaning it is easy to understand and change, operates smoothly at runtime, and contains no technical debt – it results in software that is maintainable, reliable, of quality, and secure.
“Code is one of the most valuable assets in a digital economy. As companies adopt AI and move to the cloud, we want them to continue having seamless access to Sonar’s Clean Code solutions as part of their DevOps environment in the cloud,” said Harry Wang, VP of Strategic Partnerships & Head of Product Marketing at Sonar. “SonarQube availability on Google Cloud Marketplace means that organizations can easily combine Google’s AI capabilities with the familiar Clean Code solution that they trust, to evolve and accelerate software development safely and responsibly.”
SonarQube is an essential tool in the current DevOps toolchain as it reduces issues before they reach production, reduces rollbacks and rework, increases developer velocity, and increases DevOps efficiency and agility. By preventing new issues from entering into production, software becomes easier to maintain and businesses become more competitive, as new features are faster to add.
Key benefits of its availability on Google Cloud Marketplace include:
- Faster Setup: Get up and running with SonarQube quickly and easily, eliminating the need for complex manual installations.
- Seamless Integration: Developers can incorporate SonarQube into their Google Cloud environment with the ease of container deployment on Google Kubernetes Engine (GKE).
- Scalability: Usage of SonarQube can easily scale with Google Cloud’s infrastructure to match evolving needs, no matter the size of the organization or software project.
- Simplified Billing and Cost Effectiveness: Companies can consolidate the purchase of SonarQube with the rest of their cloud spending to achieve better discounts on Google Cloud and reduce administrative overhead.
To learn more about SonarQube, visit here. SonarQube is generally available now on Google Cloud Marketplace.
About Sonar
Sonar is a leading maker of open source solutions to help developers write Clean Code. Sonar’s solutions — SonarQube, SonarCloud, and SonarLint — support over 30 programming languages, frameworks, and infrastructure technologies. Trusted by more than 400,000 organizations globally to clean more than half a trillion lines of code, Sonar is integral to delivering higher quality, better-performing software.
To learn more about Sonar, please visit https://www.sonarsource.com/.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240529150627/en/
Contact information
Media
Katie Hyman
Senior PR Manager, Sonar
katie.hyman@sonarsource.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Daiichi Sankyo Shines a Light on Inequalities and Unmet Needs in Care as Part of Its Commitment to People With Cardiovascular Disease31.8.2024 18:00:00 EEST | Press release
Daiichi Sankyo Europe, (hereafter, Daiichi Sankyo) today announced its reinforced commitment to addressing key unmet needs and barriers in cardiovascular (CV) care, by shining a light on inequalities in treatment and outcomes experienced by various patient groups. The announcement follows the presentation of data from sub-analyses of the SANTORINI observational study and ETNA-AF (Edoxaban Treatment in routiNe clinical prActice in patients with nonvalvular Atrial Fibrillation) study programme, at the European Society of Cardiology (ESC) Congress 2024. Gender inequalities in CV disease treatment and LDL-C goal attainment Raised low-density lipoprotein cholesterol (LDL-C) is a key modifiable contributor to risk of cardiovascular major events. It has been shown that for every 1 mmol/L reduction in LDL-C, there is a 22% reduction in major cardiovascular events after 1 year.7,8 Female patients in Europe who are at high or very high CV risk were undertreated and less achieved guideline-recomm
Suzano completes purchase of 15% stake in Lenzing AG31.8.2024 01:40:00 EEST | Press release
Suzano, the world's largest pulp producer, today announces the completion of its acquisition of a 15% stake in Lenzing AG, the Vienna-listed leading global supplier of sustainable premium cellulosic fibres for the textile and non-wovens industry, from B&C Group. As announced in June this year, the transaction value is EUR 230 million (or EUR 39.70 per share). The agreement was subject to regulatory approval, which was granted without restrictions. The long-term partnership between Suzano and B&C Group establishes that Suzano has the right to hold two seats on Lenzing’s Board and the option to acquire an additional 15% stake from B&C Group until the end of 2028. Following the sale of the 15% stake, B&C Group now holds 37.25% of Lenzing’s share capital. Lenzing is a leading global supplier of premium wood-based cellulosic fibers (lyocell, modal, and viscose) for the production of clothing, home textiles, hygiene products, and non-woven materials. Beto Abreu, CEO of Suzano, said: “Lenzing
Ant International Collaborates with Brazilian Partners to Drive Financial Inclusion with Innovative Credit Tech Solutions30.8.2024 21:46:00 EEST | Press release
Ant International, a digital payment and financial technology leader, today announced its strategic initiative to provide AI-driven credit technology solutions designed to empower local partners and advance financial inclusions in Brazil. As a major milestone, Ant International has formed a strategic partnership with Dock, a leader in payments and banking technology in Latin America. This collaboration aims to enhance the credit management capability and infrastructure efficiency for Dock’s clients, which include financial institutions, retailers, fintech start-ups, etc. The shared vision is to make credit services more inclusive for market segments that are currently insufficiently served, such as micro, small and medium-sized enterprises (MSMEs). In the initial phase of the collaboration, Ant International’s AI-driven credit tech solutions, including an automated and intelligent risk management engine, will be explored for integration into Dock One platform. This initiative aims to s
Wipro Appoints Srikumar Rao as Global Head of Its Engineering Edge Business Line30.8.2024 17:20:00 EEST | Press release
Wipro Limited (NYSE: WIT, BSE: 507685, NSE: WIPRO), a leading technology services and consulting company, today announced the appointment of Srikumar Rao as Global Head of its Engineering Edge Business Line, effective from October 5, 2024. Srikumar succeeds Harmeet Chauhan, who is stepping down to pursue opportunities outside the organization. Srikumar will report to Srini Pallia. Srikumar has been with Wipro for 26 years and has grown with the organization, serving in various leadership roles. He was most recently the Chief Operating Officer (COO) of Wipro Engineering Edge (WEE) and Global Practice Head of Embedded Systems. His work has spanned several markets, selling and delivering specialized Engineering, Research, and Development (ER&D) services to Software & Internet, Semiconductor, Automotive, Manufacturing, and Communications clients. In his new role, Srikumar will continue to scale and strengthen Wipro’s engineering prowess. He will also be responsible for defining the vision
Alnylam Presents Detailed Results from the Positive HELIOS-B Phase 3 Study of Vutrisiran▼ in Patients with ATTR Amyloidosis with Cardiomyopathy at the European Society of Cardiology Congress30.8.2024 13:00:00 EEST | Press release
Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced detailed results from the HELIOS-B Phase 3 study of vutrisiran, an investigational RNAi therapeutic in development for the treatment of ATTR amyloidosis with cardiomyopathy (ATTR-CM). The data were presented today in a Hot Line session at the European Society of Cardiology (ESC) Congress 2024, taking place August 30-September 2 in London, United Kingdom. Results from the HELIOS-B study were also simultaneously published in TheNew England Journal of Medicine. As previously reported, the HELIOS-B study met all 10 of its primary and secondary endpoints, across both the overall and monotherapy populations, with statistical significance. Enrolled patients were predominantly New York Heart Association (NYHA) Class I or II with wild-type disease and had been diagnosed by non-invasive methods, with substantial concurrent treatment with available standard of care treatments such as tafamidis and
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom